These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 11450095)

  • 1. Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.
    Pluta R; Miziak B; Czuczwar SJ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer's Disease.
    Pluta R; Januszewski S; Jabłoński M
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Ischemia as a Prelude to Alzheimer's Disease.
    Pluta R; Januszewski S; Czuczwar SJ
    Front Aging Neurosci; 2021; 13():636653. PubMed ID: 33679381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
    Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration.
    Pluta R; Januszewski S; Czuczwar SJ
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32605320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.
    Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.
    Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.
    Pluta R; Ułamek-Kozioł M; Czuczwar SJ
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCA7 in Alzheimer's Disease.
    Zhao QF; Yu JT; Tan MS; Tan L
    Mol Neurobiol; 2015; 51(3):1008-16. PubMed ID: 24878767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
    Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
    Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with D3 removes amyloid deposits, reduces inflammation, and improves cognition in aged AβPP/PS1 double transgenic mice.
    van Groen T; Kadish I; Funke SA; Bartnik D; Willbold D
    J Alzheimers Dis; 2013; 34(3):609-20. PubMed ID: 23271316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.
    Pluta R; Amek MU
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):855-64. PubMed ID: 19183778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers.
    Crossgrove JS; Smith EL; Zheng W
    Brain Res; 2007 Mar; 1138():187-95. PubMed ID: 17276414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A computational positron emission tomography simulation model for imaging beta-amyloid in mice.
    Simmons MK; Manjeshwar R; Agdeppa ED; Mattheyses RM; Kiehl TR; Montalto MC
    Mol Imaging Biol; 2005; 7(1):69-77. PubMed ID: 15912278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible reverse transport of beta-amyloid peptide across the blood-brain barrier.
    Pluta R; Misicka A; Barcikowska M; Spisacka S; Lipkowski AW; Januszewski S
    Acta Neurochir Suppl; 2000; 76():73-7. PubMed ID: 11450095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of human beta-amyloid peptide through the rat blood-brain barrier after global cerebral ischemia.
    Pluta R; Misicka A; Januszewski S; Barcikowska M; Lipkowski AW
    Acta Neurochir Suppl; 1997; 70():247-9. PubMed ID: 9416336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide.
    Pluta R; Barcikowska M; Januszewski S; Misicka A; Lipkowski AW
    Neuroreport; 1996 May; 7(7):1261-5. PubMed ID: 8817545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
    Davies TA; Long HJ; Eisenhauer PB; Hastey R; Cribbs DH; Fine RE; Simons ER
    Amyloid; 2000 Sep; 7(3):153-65. PubMed ID: 11019856
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.